Fluoro-modified chemotactic peptides: fMLF analogues

Journal of Peptide Science

Volumn 10, Issue 2, 2004, Pages 67-81

  Koksch, Beate ^a   Dahl, Christina ^a   Radics, Gabor ^a   Vocks, Andreas ^a   Arnold, Klaus ^a   Arnhold, Jürgen ^a   Sieler, Joachim ^a   Burger, Klaus ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

C ; C trifluoromethylalanine; C* difluromethylalanine; Chemiluminescence; Chemotactic peptide fluoro modified peptides; Diflurethylglycine

Indexed keywords

CARBON; CHEMOTACTIC PEPTIDE; FLUORINE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; LUMINOL; PEPTIDE DERIVATIVE; PEPTIDE LIBRARY;

ALKYLATION; AMINO ACID SUBSTITUTION; ARTICLE; CELL ACTIVITY; CHEMICAL INTERACTION; CHEMICAL MODIFICATION; CHEMICAL STRUCTURE; CHEMOLUMINESCENCE; CONTROLLED STUDY; FLUORINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYDROPHOBICITY; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATION; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; THIN LAYER CHROMATOGRAPHY;

CHEMOTAXIS; FLUORESCENCE; HUMANS; KINETICS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; PEPTIDES; PROTEIN STRUCTURE, TERTIARY;

EID: 1342323712     PISSN: 10752617     EISSN: None     Source Type: Journal    
DOI: 10.1002/psc.515     Document Type: Article

References (52)

1. Becker EL, Freer RJ, Toniolo C, Balaram P. The specificity of the chemotactic formyl peptide receptor of rabbit neutrophils. In Membrane Receptors and Cellular Regulation, Czech MP, Kahn CR (eds). Liss: New York, 1985; 129-134.
2. Tornoe CW, Sengelov H, Meldal M. Solid-phase synthesis of chemotactic peptides using α-azido acids. J. Peptide Sci. 2000; 6: 314-320.
3. Pirrung MC, Drabik SJ, Ahamed J, Ali H. Caged chemotactic peptides. Bioconj. Chem. 2000; 11: 679-681.
4. Schiffmann E, Corcoran BA, Wahl SM. N-Formyl-methionyl peptides as chemoattractants for leukocytes. Proc. Natl. Acad. Sci. USA 1975; 72: 1059-1062.
5. Schiffmann E, Showell HJ, Corcoran BA, Ward PA, Smith E, Becker EL. The isolation and partial characterization of neutrophil chemotactic factors from Escherichia coli. J. Immunol. 1975; 114: 1831-1837.
6. Toniolo C, Formaggio F, Crisma M, Valle G, Boesten WHJ, Schoemaker HE, Kamphuis J, Temussi PA, Becker EL, Précigoux G. Bioactive and model peptides characterized by the helicogenic (αMe Phe residue. Tetrahedron 1993; 49: 3641-3653.
7. Becker EL. The formylpeptide receptor of the neutrophil. Am. J. Path. 1987; 129: 15-24.
8. McPhail LC, Harvath L. Signal transduction in neutrophil oxidative metabolism and chemotaxis. In The Natural Immune System: The Neutrophil, Abramson JS, Wheeler JG (eds). Oxford University Press: Oxford, 1993; 63-77.
9. Torrini I, Zecchini GP, Paradisi MP, Lucente G, Gavuzzo E, Mazza F, Pochetti G, Spisani F, Guliani AL. Synthesis and properties of chemotactic peptide analogs. II. HCO-Met-Leu-Phe-OMe analogs containing cyclic α, α-disubstituted amino acids as Met and Phe mimicking residues. Int. J. Peptide Protein Res. 1991; 38: 495-504.
10. α,α-dialkylated glycine at position 2. Peptide Res. 1989; 2: 275-281.
11. Benedetti E. X-ray crystallography of peptides. Biopolymers (Peptide Sci.) 1996; 40: 3-44.
12. Sukumar MP, Raz AP, Balaram P, Becker EL. A highly active chemotactic peptide analog incorporating the unusual residue 1-aminocyclohexanecarboxylic acid at position 2. Biochem. Biophys. Res. Commun. 1985; 128: 339-344.
13. Prasad S, Rao RB, Bergstrand H, Lundquist B, Becker EL, Balaram P. Conformation-activity correlations of chemotactic tripeptide analogs incorporating dialkyl residues with linear and cyclic alkyl sidechains at position 2. Int. J. Peptide Protein Res. 1996; 48: 312-318.
14. Freer RJ, Day AR, Schiffmann E, Aswanikumar S, Showell HJ, Becker EL. Further studies on the structural requirements for synthetic peptide chemoattractants. Biochemistry 1980; 19: 2404-2409.
15. Freer RJ, Day AR, Muthukumaraswamy N, Pinon D, Wu A, Showell HJ, Becker EL. Formyl peptide chemoattractants. A model of the receptor in rabbit neutrophils. Biochemistry 1982; 21: 257-263.
16. α-formyl-norleucyl-leucyl-phenylalanine. FEBS Lett. 1977; 77: 291-294.
17. Shimohigashi Y. In Opioid Peptides, Medicinal Chemistry, Rapka RS, Bernett G, Hawks RL (eds). NIDA Research Monograph 1986; 69: 65.
18. Hruby VJ, Li G, Haskell-Luevano C, Shenderovich M. Design of peptides, proteins, and peptidomimetic in Chi space. Biopolymers 1997; 43: 219-266.
19. 2)Phe, as molecular explorers for the CH/π interaction between peptide ligand and receptor. Tetrahedron Lett. 2000; 41: 923-927.
20. Nishio M, Umezawa Y, Hirota M, Takeuchi Y. The CH/π interaction: significance in molecular recognition. Tetrahedron 1995; 51: 8665-8701.
21. Erickson JA, Mc Loughlin JI. Hydrogen bond donor properties of the difluoromethyl group. J. Org. Chem. 1995; 60: 1626-1631.
22. Caminati W, Melandri S, Moreschini P, Favero PG. The C-F⋯H-C 'anti-hydrogen bond' in the gas phase: microwave structure of the difluoromethane dimer. Angew. Chem. Int. Ed. 1999; 38: 2924-2925.
23. Howard JAK, Hoy VJ, O'Hagan D, Smith GT. How good is fluorine as hydrogen bond acceptor. Tetrahedron 1996; 52: 12 613-12 622.
24. O'Hagan D, Rzepta HS. Some influences of fluorine in bioorganic chemistry. J. Chem. Soc., Chem. Commun. 1997; 645-652.
25. Dunitz JD, Taylor R. Organic fluorine hardly ever accepts hydrogen bonds. Chem. Eur. J. 1997; 3: 89-98.
26. Tang Y, Ghirlanda G, Vaidehi N, Kua J, Mainz TD, Goddard WA, III, Degrado WF, Tirrell DA. Stabilization of coiled-coil peptide domains by introduction of trifluoroleucine. Biochemistry 2000; 40: 2790-2796.
27. Degrado WF, Summa CM, Pavone V, Nastri F, Lombardi A. De novo design and structural characterization of proteins and metalloproteins. Annu. Rev. Biochem. 1999; 68: 779-819.
28. Winkler D, Burger K. Synthesis of enantiomerically pure D- and L-armentomycin and its difluoro analogues from aspartic acid. Synthesis 1996; 1419-1421.
29. Sewald N, Hollweck W, Mütze K, Schierlinger K, Seymour LC, Gaa K, Burger K, Koksch B, Jakubke HD. Peptide modification by introduction of α-trifluoromethyl substituted amino acids. Amino Acids 1995; 8: 187-195.
30. Sewald N, Burger K. Synthesis of β-fluoro-containing amino acids. In Fluorine-containing Amino Acids, Synthesis and Properties, Kukhar VP, Soloshonok VA (eds). Wiley: Chichester 1995; 139-162.
31. Osipov SN, Golubev AS, Sewald N, Michel T, Kolomiets AF, Fokin AV, Burger K. A new strategy for the synthesis of β-difluoromethyl substituted α-hydroxy and α-amino acids. J. Org. Chem. 1996; 61: 7521-7528.
32. Preliminary results have been published: Moroni M, Koksch B, Burger K. Analogues of chemotactic peptides containing fluorinated amino acids. Peptides; Proceedings of the 26th European Peptide Symposium, Martinez J, Fehrentz J-A (eds.). EDK: Paris 2001; 689-690.
33. Duczek W, Deutsch J, Vieth S, Niclas H-S. A simple and convenient synthesis of N-formyl amino acid esters under mild conditions. Synthesis 1996; 37-38.
34. Sheldrick GM. SHELXS 97. Program Used to Solve and to Refine Structure. University of Göttingen: Göttingen, Germany, 1997.
35. Crystallographic data have been deposited at the Cambridge Crystallographic Data Centre, CCDC210454. Copies of this information may be obtained free of charge from The Director, CCDC, 12 Union Road, Cambridge, CB2 1EZ, UK (fax: +44 1233 336033, e-mail: depositγcdc.cam.ac.uk or http://www.ccdc.cam.ac.uk).
36. Bardi R, Piazzesi AM, Toniolo C, Antony Raj P, Raghothama S, Balaram P. Solid state and solution conformation of Boc-L-Met-Aib-L-Phe-OMe. Int. J. Peptide Protein Res. 1986; 27: 229-238.
37. Iqbal M, Balaram P, Showell HJ, Freer RJ, Becker EL. Conformationally constrained chemotactic peptide analogs of high biological activity. FEBS Lett. 1984; 165: 171-174.
38. Koksch B, Sewald N, Burger K, Jakubke H-D. Peptide modification by incorporation of α-trifluoromethyl substituted amino acids. Amino Acids 1996; 11: 425-434.
39. Michel T, Koksch B, Osipov SN, Golubev AN, Sieler J, Burger K. Peptide synthesis with α-(difluoromethyl)-substituted amino acids. Coll. Czech. Chem. Commun. 2000; 67: 1533-1553.
40. Koksch B, Sewald N, Hofmann H-J, Burger K, Jakubke H-D. Proteolytically stable peptides by incorporation of α-Tfm amino acids. J Peptide Sci. 1997; 3: 157-167.
41. Watson F, Robinson JJ, Edwards SW. Sequential phospholipase activation in the stimulation of the neutrophil NADPH-oxidase. FEMS Microbiol. Immunol. 1992; 105: 239-248.
42. Curnutte JT, Erikson RW, Ding J, Badwey JA. Reciprocal interactions between protein kinase C and components of the NADPH-oxidase complex may regulate superoxide production by neutrophils stimulated by a phorbol ester. J. Biol. Chem. 1994; 269: 10 813-10 819.
43. Waite KA, Wallin R, Qualliotine-Mann D, McPhail LC. Phosphatidic acid-mediated phosphorylation of the NADPH oxidase component p47phox. J. Biol. Chem. 1997; 272: 15 569-15 578.
44. Arnhold J, Benard S, Kilian U, Reichl S, Schiller J, Arnold K. Modulation of luminol chemiluminescence of fmet-leu-phe-stimulated neutrophils by affecting dephosphorylation and the metabolism of phosphatidic acid. Luminescence 1999; 14: 1-9.
45. Segal AW, Abo A. The biochemical basis of the NADPH oxidase of phagocytes. Trends Biochem. Sci. 1993; 18: 43-47.
46. Le Y, Yang Y, Cui Y, Yazawa H, Gong W, Qiu C, Wang JM. Receptors for chemotactic formyl peptides as pharmacological targets. Int. Immunopharmacol. 2002; 2: 1-13.
47. Le Y, Oppenheim JJ, Wang JM. Pleiotropic roles of formyl peptide receptors. Cytokine Growth Factor Rev. 2001; 12: 91-105.
48. Dalpiaz A, Scatturin A, Vertuani G, Pecoraro R, Borea PA, Varani K, Traniello S, Spisani S. Met-Ile-Phe-Leu derivatives: full and partial agonists of human neutrophil formylpeptide receptors. Eur. J. Pharmacol. 2001; 411: 327-333.
49. Bender JG, van Epps DE. Analysis of the bimodal chemiluminescence pattern stimulated in human neutrophils by chemotactic factors. Infect. Immunol. 1983; 41: 1062-1070.
50. Dahlgren C. Polymorphonuclear leukocyte chemiluminescence induced by formylmethionyl-leucyl-phenylalanine and phorbol myristate acetate: effects of catalase and superoxide dismutase. Agent Actions 1987; 21: 104-112.
51. Ulrich AS. In Encyclopedia of Spectroscopy and Spectrometry, Lindon J, Tranter G, Holmes J (eds). Academic Press: New York, 2000; 813.
52. Koksch B, Sewald N, Jakubke H-D, Burger K. In Biomedical Frontiers of Fluorine Chemistry, Ojima I, McCarthy JR, Welch JT (eds). ACS Symposium Series, American Chemical Society: Washington, DC, 1996; 639: 42-58.